Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Erik J Dasbach"'
Autor:
Mari Nygård, Bo Terning Hansen, Joakim Dillner, Christian Munk, Kristján Oddsson, Laufey Tryggvadottir, Maria Hortlund, Kai-Li Liaw, Erik J Dasbach, Susanne Krüger Kjær
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e88323 (2014)
BACKGROUND: Infection with high-risk human papillomavirus (HPV) is causally related to cervical, vulvar and vaginal pre-invasive neoplasias and cancers. Highly effective vaccines against HPV types 16/18 have been available since 2006, and are current
Externí odkaz:
https://doaj.org/article/8bf37c0ee55b42d4b28d6dce09604f31
Autor:
Michelle G. Goveia, Lyn Finelli, T. Christopher Mast, David Heyman, Craig S. Roberts, Erik J. Dasbach
Publikováno v:
Vaccine: X
Vaccine: X, Vol 7, Iss, Pp 100084-(2021)
Vaccine: X, Vol 7, Iss, Pp 100084-(2021)
Highlights • Vaccine preventable diseases continue to impact human health. • Web-based geographic temporal visualizations of large datasets were developed. • Data on rotavirus vaccination uptake and related medical visits was used as an example
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22d24fb92010c6922906c38ff521c799
Autor:
Morgan A. Marks, Matthew Pilsbury, Wail A. Hayajneh, Cerise K. James, Erik J. Dasbach, Camilo J. Acosta, Vincent J. Daniels, Muhammet Nabi Kanıbir, Elamin H. Elbasha, Michelle G. Goveia
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-12 (2018)
BMC Infectious Diseases
BMC Infectious Diseases
Background As the socioeconomic conditions in Jordan have improved over recent decades the disease and economic burden of Hepatitis A has increased. The purpose of this study is to assess the potential health and economic impact of a two-dose hepatit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f559938e307a0f2aafa8655fc2f38945
http://link.springer.com/article/10.1186/s12879-018-3034-8
http://link.springer.com/article/10.1186/s12879-018-3034-8
Autor:
Elamin H. Elbasha, Erik J. Dasbach
Publikováno v:
PharmacoEconomics. 35:673-683
Decision-analytic models for cost-effectiveness analysis are developed in a variety of software packages where the accuracy of the computer code is seldom verified. Although modeling guidelines recommend using state-of-the-art quality assurance and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2173ba6b8a1fba13d328c9efaaaef40e
https://doi.org/10.1007/s40273-017-0508-2
https://doi.org/10.1007/s40273-017-0508-2
Publikováno v:
PharmacoEconomics. 33:777-781
Decision-analytic models are increasingly used to inform decisions about whether or not to publicly fund new health technologies such as pharmaceuticals. Therefore, few would argue the need for developing and using high-quality models [1]. Over the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8112847654e7ee6e3c18633bdf03bdce
https://doi.org/10.1007/s40273-015-0274-y
https://doi.org/10.1007/s40273-015-0274-y
Autor:
Jane H. Zhang, Robbin F. Itzler, Camilo J. Acosta, Erik J. Dasbach, Gary R. Johnson, Ruifeng Xu, Robert F. Betts, James M. Pellissier, Vicki A. Morrison, Ivan S. F. Chan, Xiaoming Li
Publikováno v:
Vaccine. 33:1499-1505
Since 2006, the vaccine, ZOSTAVAX(®), has been licensed to prevent herpes zoster. Only limited clinical follow-up data are available to evaluate duration of protection, an important consideration when developing HZ vaccination policy recommendations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e782c21eff1331bcc6d3116fba5f6a8a
https://doi.org/10.1016/j.vaccine.2014.10.039
https://doi.org/10.1016/j.vaccine.2014.10.039
Publikováno v:
Emerging Infectious Diseases, Vol 13, Iss 1, Pp 28-28 (2007)
We present a transmission dynamic model that can assess the epidemiologic consequences and cost-effectiveness of alternative strategies of administering a prophylactic quadrivalent (types 6/11/16/18) human papillomavirus (HPV) vaccine in a setting of
Externí odkaz:
https://doaj.org/article/f780f0d4311d4a648a4944297b663c51
Publikováno v:
Value in Health Regional Issues. 2:92-97
Objective We assessed the epidemiological and economic impact of a quadrivalent human papillomavirus (HPV) (6/11/16/18) vaccine for females in preventing cervical cancer, cervical intraepithelial neoplasia grades 2 and 3 (CIN 2/3), cervical intraepit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab12f883320bc4847f43192aa5455bc4
https://doi.org/10.1016/j.vhri.2013.02.001
https://doi.org/10.1016/j.vhri.2013.02.001
Autor:
Kai Li Liaw, Christian Munk, Erik J. Dasbach, Kirsten Egebjerg Jensen, Pär Sparén, Laufey Tryggvadottir, Susanne K. Kjaer, Mari Nygård
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 90:459-467
Objective Sexual behavior is of public health interest because of the association with reproductive health and sexually transmitted infections such as human papillomavirus, which is the causal factor of cervical cancer. The aim of the study was to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e4dad61228e9c45cd04283824aadceb
https://doi.org/10.1111/j.1600-0412.2010.01066.x
https://doi.org/10.1111/j.1600-0412.2010.01066.x
Autor:
Elamin H. Elbasha, Erik J. Dasbach
Publikováno v:
Vaccine. 28:6858-6867
We assessed the public health impact and value of vaccinating boys and men with the quadrivalent HPV vaccine in the United States. We used mathematical population models, accounting for both the direct and indirect protective effects of vaccination.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::888cf62c0c6e00771e1ecbc6bdb6bcfb
https://doi.org/10.1016/j.vaccine.2010.08.030
https://doi.org/10.1016/j.vaccine.2010.08.030